BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 31604821)

  • 1. Differential regulation of AMP-activated protein kinase in healthy and cancer cells explains why V-ATPase inhibition selectively kills cancer cells.
    Bartel K; Müller R; von Schwarzenberg K
    J Biol Chem; 2019 Nov; 294(46):17239-17248. PubMed ID: 31604821
    [TBL] [Abstract][Full Text] [Related]  

  • 2. V-ATPase inhibition by archazolid leads to lysosomal dysfunction resulting in impaired cathepsin B activation in vivo.
    Kubisch R; Fröhlich T; Arnold GJ; Schreiner L; von Schwarzenberg K; Roidl A; Vollmar AM; Wagner E
    Int J Cancer; 2014 May; 134(10):2478-88. PubMed ID: 24166050
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective upregulation of TNFα expression in classically-activated human monocyte-derived macrophages (M1) through pharmacological interference with V-ATPase.
    Thomas L; Rao Z; Gerstmeier J; Raasch M; Weinigel C; Rummler S; Menche D; Müller R; Pergola C; Mosig A; Werz O
    Biochem Pharmacol; 2017 Apr; 130():71-82. PubMed ID: 28189727
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The vacuolar-type ATPase inhibitor archazolid increases tumor cell adhesion to endothelial cells by accumulating extracellular collagen.
    Luong B; Schwenk R; Bräutigam J; Müller R; Menche D; Bischoff I; Fürst R
    PLoS One; 2018; 13(9):e0203053. PubMed ID: 30204757
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glucose starvation increases V-ATPase assembly and activity in mammalian cells through AMP kinase and phosphatidylinositide 3-kinase/Akt signaling.
    McGuire CM; Forgac M
    J Biol Chem; 2018 Jun; 293(23):9113-9123. PubMed ID: 29540478
    [TBL] [Abstract][Full Text] [Related]  

  • 6. AMP-activated protein kinase inhibits alkaline pH- and PKA-induced apical vacuolar H+-ATPase accumulation in epididymal clear cells.
    Hallows KR; Alzamora R; Li H; Gong F; Smolak C; Neumann D; Pastor-Soler NM
    Am J Physiol Cell Physiol; 2009 Apr; 296(4):C672-81. PubMed ID: 19211918
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The V-ATPase-inhibitor archazolid abrogates tumor metastasis via inhibition of endocytic activation of the Rho-GTPase Rac1.
    Wiedmann RM; von Schwarzenberg K; Palamidessi A; Schreiner L; Kubisch R; Liebl J; Schempp C; Trauner D; Vereb G; Zahler S; Wagner E; Müller R; Scita G; Vollmar AM
    Cancer Res; 2012 Nov; 72(22):5976-87. PubMed ID: 22986742
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-leukemic effects of the V-ATPase inhibitor Archazolid A.
    Zhang S; Schneider LS; Vick B; Grunert M; Jeremias I; Menche D; Müller R; Vollmar AM; Liebl J
    Oncotarget; 2015 Dec; 6(41):43508-28. PubMed ID: 26496038
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting V-ATPase in primary human monocytes by archazolid potently represses the classical secretion of cytokines due to accumulation at the endoplasmic reticulum.
    Scherer O; Steinmetz H; Kaether C; Weinigel C; Barz D; Kleinert H; Menche D; Müller R; Pergola C; Werz O
    Biochem Pharmacol; 2014 Oct; 91(4):490-500. PubMed ID: 25107704
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of proximal tubule vacuolar H(+)-ATPase by PKA and AMP-activated protein kinase.
    Al-bataineh MM; Gong F; Marciszyn AL; Myerburg MM; Pastor-Soler NM
    Am J Physiol Renal Physiol; 2014 May; 306(9):F981-95. PubMed ID: 24553431
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and activity of the archazolid western hemisphere.
    Tran AB; Melly GC; Doucette R; Ashcraft B; Sebren LJ; Havko N; Young JC; O'Neil GW
    Org Biomol Chem; 2011 Oct; 9(22):7671-4. PubMed ID: 21931924
    [TBL] [Abstract][Full Text] [Related]  

  • 12. AKT Ser/Thr kinase increases V-ATPase-dependent lysosomal acidification in response to amino acid starvation in mammalian cells.
    Collins MP; Stransky LA; Forgac M
    J Biol Chem; 2020 Jul; 295(28):9433-9444. PubMed ID: 32409581
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Resistance mechanisms of cancer cells to the novel vacuolar H(+)-ATPase inhibitor archazolid B.
    Hamm R; Sugimoto Y; Steinmetz H; Efferth T
    Invest New Drugs; 2014 Oct; 32(5):893-903. PubMed ID: 25065443
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diallyl trisulfide induces apoptosis and mitotic arrest in AGS human gastric carcinoma cells through reactive oxygen species-mediated activation of AMP-activated protein kinase.
    Choi YH
    Biomed Pharmacother; 2017 Oct; 94():63-71. PubMed ID: 28753455
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design, synthesis, and biological evaluation of novel analogues of archazolid: a highly potent simplified V-ATPase inhibitor.
    Menche D; Hassfeld J; Sasse F; Huss M; Wieczorek H
    Bioorg Med Chem Lett; 2007 Mar; 17(6):1732-5. PubMed ID: 17239591
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vacuolar-ATPase Inhibition Blocks Iron Metabolism to Mediate Therapeutic Effects in Breast Cancer.
    Schneider LS; von Schwarzenberg K; Lehr T; Ulrich M; Kubisch-Dohmen R; Liebl J; Trauner D; Menche D; Vollmar AM
    Cancer Res; 2015 Jul; 75(14):2863-74. PubMed ID: 26018087
    [TBL] [Abstract][Full Text] [Related]  

  • 17. V-ATPase inhibition increases cancer cell stiffness and blocks membrane related Ras signaling - a new option for HCC therapy.
    Bartel K; Winzi M; Ulrich M; Koeberle A; Menche D; Werz O; Müller R; Guck J; Vollmar AM; von Schwarzenberg K
    Oncotarget; 2017 Feb; 8(6):9476-9487. PubMed ID: 28036299
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mode of cell death induction by pharmacological vacuolar H+-ATPase (V-ATPase) inhibition.
    von Schwarzenberg K; Wiedmann RM; Oak P; Schulz S; Zischka H; Wanner G; Efferth T; Trauner D; Vollmar AM
    J Biol Chem; 2013 Jan; 288(2):1385-96. PubMed ID: 23168408
    [TBL] [Abstract][Full Text] [Related]  

  • 19. AMP-activated protein kinase regulates the vacuolar H+-ATPase via direct phosphorylation of the A subunit (ATP6V1A) in the kidney.
    Alzamora R; Al-Bataineh MM; Liu W; Gong F; Li H; Thali RF; Joho-Auchli Y; Brunisholz RA; Satlin LM; Neumann D; Hallows KR; Pastor-Soler NM
    Am J Physiol Renal Physiol; 2013 Oct; 305(7):F943-56. PubMed ID: 23863464
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and biological evaluation of a water-soluble derivative of the potent V-ATPase inhibitor archazolid.
    Persch E; Basile T; Bockelmann S; Huss M; Wieczorek H; Carlomagno T; Menche D
    Bioorg Med Chem Lett; 2012 Dec; 22(24):7735-8. PubMed ID: 23122818
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.